225 related articles for article (PubMed ID: 33576454)
1. Long non‑coding RNA
Wang K; Hu YB; Zhao Y; Ye C
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576454
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
Song L; Huang Y; Zhang X; Han S; Hou M; Li H
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway.
Lin X; Feng D; Li P; Lv Y
Cancer Med; 2020 Nov; 9(21):8122-8132. PubMed ID: 32918541
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
Liu S; Yang Y; Wang W; Pan X
J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
7. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
Feng S; Sun H; Zhu W
Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway.
Xiao L; Shi XY; Li ZL; Li M; Zhang MM; Yan SJ; Wei ZL
J Gynecol Oncol; 2021 Sep; 32(5):e77. PubMed ID: 34132072
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
Zeng Y; Xu Q; Xu N
Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation.
Wang Q; Liu L; Zhang S; Ming Y; Liu S; Cheng K; Zhao Y
Exp Mol Med; 2020 Mar; 52(3):461-472. PubMed ID: 32157157
[TBL] [Abstract][Full Text] [Related]
12. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
Guo C; Wang X; Liang L
Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
[TBL] [Abstract][Full Text] [Related]
13. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
[TBL] [Abstract][Full Text] [Related]
14. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
15. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
16. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA DUXAP8 regulates proliferation and apoptosis of ovarian cancer cells via targeting miR-590-5p.
Meng Q; Li Z; Pan J; Sun X
Hum Cell; 2020 Oct; 33(4):1240-1251. PubMed ID: 32749665
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
19. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
Wang Q; Ding J; Nan G; Lyu Y; Ni G
J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
